Department of Pediatrics

Education

• BS, University of Missouri-Rolla, 2004
• MD, University of Alabama School of Medicine, 2013
• PhD, University of Alabama-Birmingham, 2011

Training

• Pediatrics Residency, Washington University in St. Louis / St. Louis Children's Hospital, 2013 - 2016
• Pediatric Hematology/Oncology Fellow, Washington University in St. Louis / St. Louis Children's Hospital, 2016 - 2019

Licensure and Board Certification

• 2017 - PresMO, Medical License
• 2017 - PresABP Board Certified (General Pediatrics)

Honors and Awards

• ASIP Trainee Travel Award to Experimental Biology 2008, 2008
• HCS Travel Award to Experimental Biology 2008, 2008
• ASIP Abraham D. Sobel Educational Fund Scholar Award 2009, 2009
• HCS Histochemist-in-Training Award 2009, 2009
• CTF First Time Conference Travel Award, 2019

Recent Publications view all (9)

Publication Co-Authors

David H. Gutmann, MD, PhD, FAAN

Amy Armstrong

Washington University has a long tradition of collaboration amongst colleagues.The faculty above have co-authored publications with Nicole Brossier

1. Armstrong AE, Brossier NM, Hirbe AC. Neurofibromatosis type 1-related tumours in paediatrics: an evolving treatment landscape. Lancet Child Adolesc Health. 2020;4(7):488-490. PMID:32562630 
2. Brossier NM, Prechtl AM, Longo JF, Barnes S, Wilson LS, Byer SJ, Brosius SN, Carroll SL. Classic Ras Proteins Promote Proliferation and Survival via Distinct Phosphoproteome Alterations in Neurofibromin-Null Malignant Peripheral Nerve Sheath Tumor Cells. J Neuropathol Exp Neurol. 2015;74(6):568-86. PMCID:PMC4433624  PMID:25946318 
3. Brossier NM, Gutmann DH. Improving outcomes for neurofibromatosis 1-associated brain tumors. Expert Rev Anticancer Ther. 2015;15(4):415-23. PMID:25652347 
4. Brosius SN, Turk AN, Byer SJ, Brossier NM, Kohli L, Whitmire A, Mikhail FM, Roth KA, Carroll SL. Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis. Acta Neuropathol. 2014;127(4):573-91. PMCID:PMC3999224  PMID:24232507 
5. Kohli L, Kaza N, Coric T, Byer SJ, Brossier NM, Klocke BJ, Bjornsti MA, Carroll SL, Roth KA. 4-Hydroxytamoxifen induces autophagic death through K-Ras degradation. Cancer Res. 2013;73(14):4395-405. PMCID:PMC3715566  PMID:23722551 
6. Byer SJ, Brossier NM, Peavler LT, Eckert JM, Watkins S, Roth KA, Carroll SL. Malignant peripheral nerve sheath tumor invasion requires aberrantly expressed EGF receptors and is variably enhanced by multiple EGF family ligands. J Neuropathol Exp Neurol. 2013;72(3):219-33. PMCID:PMC3579504  PMID:23399900 
7. Kazmi SJ, Byer SJ, Eckert JM, Turk AN, Huijbregts RP, Brossier NM, Grizzle WE, Mikhail FM, Roth KA, Carroll SL. Transgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesis. Am J Pathol. 2013;182(3):646-67. PMCID:PMC3586689  PMID:23321323 
8. Brossier NM, Carroll SL. Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system. Brain Res Bull. 2012;88(1):58-71. PMCID:PMC3263419  PMID:21855613 
9. Byer SJ, Eckert JM, Brossier NM, Clodfelder-Miller BJ, Turk AN, Carroll AJ, Kappes JC, Zinn KR, Prasain JK, Carroll SL. Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner. Neuro Oncol. 2011;13(1):28-41. PMCID:PMC3018903  PMID:21075781